Outcome measurement
malignant arrhythmias, AF/AT, cardiovascular death, atrial tachycardia, atrial tachyarrhythmia, stroke, MACCEs, atrial flutter
STROKE, EVENTS, ATRIAL FLUTTER, ATRIAL TACHYCARDIA
Primary endpoint is any documented atrial tachyarrhythmia [AF, atrial flutter or atrial tachycardia (AF/AT)] lasting 30 s following a blanking period of 3 months after CMIV.Secondary endpoints are as follows: (i) any documented atrial tachyarrhythmia [AF, (AF/AT)] at the 6-month follow-up monitoring session after CMIV; (ii) any documented atrial tachyarrhythmia [AF, (AF/AT)] at the 12-month follow-up monitoring after CMIV; and (iii) major adverse cardiac or cerebrovascular events (MACCEs, including cardiovascular death, malignant arrhythmias, and stroke) at 6 or 12 months after CMIV.